- Home
- Events
- Upcoming events
- Spring market update 2025
Spring market update 2025
April 24, 202510.00, Online
Join Richard and Tom as they evaluate our economic and investment outlook for 2025 while answering any important questions you may have.
Speakers
Thomas BecketCo-Chief Investment Officer Together with Richard Champion Tom co-leads our investment process, asset allocation decisions and multi-asset model portfolio construction and is responsible for our fixed interest research. A graduate of Trinity College, Dublin, with an MA (Hons) in Classics, Tom moved to Canaccord Genuity Wealth Management as part of the acquisition of Punter Southall Wealth, where he had been Chief Investment Officer for nearly 18 years. He is an Associate of the CISI and a respected commentator in the press, particularly on markets and economic matters. |
Richard ChampionCo-Chief Investment Officer Alongside Tom Becket, Richard co-leads our investment process, asset allocation decisions and multi-asset model portfolio construction and is responsible for our equity research. Richard joined Canaccord in June 2015. Prior to this he was Chief Investment Officer at Sanlam Private Wealth, and has extensive experience running Global, European and UK equity portfolios, as well as managing money for high net worth clients. He is an Associate of the Society of Investment Professionals. |
Investment involves risk. The value of investments and the income from them can go down as well as up and you may not get back the amount originally invested. Past performance is not a reliable indicator of future performance.
Our portfolios are designed to work over a typical investment cycle of 7-10 years, so we recommend you stay invested for at least seven years.
The information provided is not to be treated as specific advice. It has no regard for the specific investment objectives, financial situation or needs of any specific person or entity.
Investment involves risk and you may not get back what you invest. It’s not suitable for everyone.
Investment involves risk and is not suitable for everyone.